As we embark on this new year, we’re taking time to reflect on the many exciting milestones that Target ALS achieved in 2024. From launching our groundbreaking Data Engine, to expanding our Global Natural History Study into Latin America, to successfully completing our $250 million capital campaign, 2024 was a testament to our values: radical collaboration, deliberate disruption, and impatient optimism in service of our mission. We successfully broke down barriers that traditionally limit scientific innovation to advance critical research that will lead to effective treatments for ALS. More important than reflection, however, we’re taking stock of our impact and strategizing our next steps to continue to shape the landscape of ALS research, molding that landscape into a world where Everyone with ALS Lives.
